Company / Capital Expenditures
Avantor Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$128.8M
FY2025
5-year range
$61.6M / $148.8M
FY2021-FY2025
Trend
-13.4%
vs FY2024
Sector context
#53 of 151
Health Care
What the data says
At $129M, Avantor's capital expenditures ranks #53 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 9 years, ranging from $25M in FY2019 to $149M in FY2024.
Based on SEC 10-K filings.
$129M in FY2025 with a 5-year CAGR of +15.9%.
Declined from $146M to $129M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +27.9%
- 5-Year CAGR
- +15.9%
- 10-Year CAGR
- -
Sector benchmark
#53 of 151 in Health CareTop 35% of 151This company $128.8M Sector average $271.7M
▼
-52.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.9%, indicating consistent growth.
- In FY2025, capital expenditures decreased 13.4% year-over-year.
- Ranks #53 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $128.8M | -13.4% |
| FY2024 | $148.8M | +1.6% |
| FY2023 | $146.4M | +137.7% |
| FY2022 | $61.6M | -44.6% |
| FY2021 | $111.1M | +80.4% |
| FY2020 | $61.6M | +144.4% |
| FY2019 | $25.2M | -33.2% |
| FY2018 | $37.7M | +49.6% |
| FY2017 | $25.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026